BCAX
Bicara Therapeutics Inc.
$18.48
-$0.37(-1.96%)
52
Overall
60
Value
63
Tech
34
Quality
Market Cap
$1.17B
Volume
2.09M
52W Range
$7.80 - $19.75
Target Price
$32.57
Key Metrics Overview
| Market Cap | $1.17B | P/E Ratio | N/A |
| 52W High | $19.75 | 52W Low | $7.80 |
| Div Yield | N/A | Payout Ratio | N/A |
| EPS Growth 3Y | N/A | 52W Position | 89.4% |
| Overall Score | 52 | Value Score | 60 |
| Quality Score | 34 | Technical Score | 63 |
Growth Analysis
| EPS Current Est | $-2.55 | EPS Next Est | $-3.11 |
| EPS Growth Est | N/A | DPS Growth 3Y | N/A |
Revenue (5Y)
No data available
EBITDA (5Y)
No data available
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | BCAX | $18.48 | -2.0% | 2.09M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Bicara Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW